Lunit Wins Stockholm Region Breast Screening Contract
Stockholm Region will deploy Lunit INSIGHT MMG across its breast cancer screening program through three designated hospitals.
This article was automatically drafted and passed editorial compliance checks. It synthesizes public source metadata and is not a substitute for individual care or clinical review.
Medical AI company Lunit has secured a contract covering Stockholm Region's breast cancer screening program. Stockholm Region will introduce the company's AI-based mammography analysis system, Lunit INSIGHT MMG, at the three hospitals responsible for screening in the region.
Deployment across three screening hospitals
Lunit will work with Swedish medical imaging company Sectra on the supply. The participating institutions are Capio S:t Göran Hospital, Karolinska University Hospital and Södersjukhuset.
From a hospital study to a regional program
Lunit's AI use in Stockholm began as a clinical study at one hospital five years earlier. Stockholm Region is now expanding that use to its region-wide screening program.
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.
